New Results
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity Nanobody
Guillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, Naphak Modhiran, Alberto A Amarilla, Johanna Himelreichs, Alexander A. Khromykh, Constanza Salinas, Teresa Pinto, Yorka Cheuquemilla, Yago Margolles, Natalia López González del Rey, Zaray Miranda-Chacon, Alexei Cuevas, Anne Berking, Camila Deride, Sebastián González-Moraga, Héctor Mancilla, Daniel Maturana, Andreas Langer, Juan Pablo Toledo, Ananda Müller, Benjamín Uberti, Paola Krall, Pamela Ehrenfeld, Javier Blesa, Pedro Chana-Cuevas, German Rehren, David Schwefel, Luis Ángel Fernandez, Alejandro Rojas-Fernandez
doi: https://doi.org/10.1101/2020.06.09.137935
Guillermo Valenzuela Nieto
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
Ronald Jara
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
2Institute of Biochemistry and Microbiology, Faculty of Sciences, Universidad Austral de Chile, Valdivia, Chile
Daniel Watterson
3School of Chemistry and Molecular Bioscience, The University of Queensland, Brisbane, Australia
4The Australian Institute for Biotechnology and Nanotechnology, The University of Queensland, Brisbane, Australia
5Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Australia
Naphak Modhiran
3School of Chemistry and Molecular Bioscience, The University of Queensland, Brisbane, Australia
4The Australian Institute for Biotechnology and Nanotechnology, The University of Queensland, Brisbane, Australia
Alberto A Amarilla
3School of Chemistry and Molecular Bioscience, The University of Queensland, Brisbane, Australia
Johanna Himelreichs
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
Alexander A. Khromykh
3School of Chemistry and Molecular Bioscience, The University of Queensland, Brisbane, Australia
5Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Australia
Constanza Salinas
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
Teresa Pinto
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
Yorka Cheuquemilla
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
7Comprehensive Neuroscience Center AC (CINAC), HM Puerta del Sur, Madrid Mostoles Hospital, 28938 Madrid, Spain
Yago Margolles
6Department of Microbial Biotechnology, National Biotechnology Center, Superior Council of Scientific Research, Madrid, Spain
Natalia López González del Rey
7Comprehensive Neuroscience Center AC (CINAC), HM Puerta del Sur, Madrid Mostoles Hospital, 28938 Madrid, Spain
Zaray Miranda-Chacon
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
Alexei Cuevas
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
Anne Berking
8Berking Biotechnology, Valdivia, Chile
Camila Deride
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
11Institute of Veterinary Clinical Sciences, Faculty of Veterinary Sciences, Universidad Austral de Chile, Valdivia, Chile
Sebastián González-Moraga
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
Héctor Mancilla
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
Daniel Maturana
9NanoTemper Technologies GmbH, Floessergasse 4, 81369 Munich, Germany
Andreas Langer
9NanoTemper Technologies GmbH, Floessergasse 4, 81369 Munich, Germany
Juan Pablo Toledo
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
Ananda Müller
10Ross University School of Veterinary Medicine, Saint Kitts and Nevis, West Indies
11Institute of Veterinary Clinical Sciences, Faculty of Veterinary Sciences, Universidad Austral de Chile, Valdivia, Chile
Benjamín Uberti
11Institute of Veterinary Clinical Sciences, Faculty of Veterinary Sciences, Universidad Austral de Chile, Valdivia, Chile
Paola Krall
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
12Department of Pediatrics and Children’s Surgery Oriente, Universidad de Chile
Pamela Ehrenfeld
13Institute of Anatomy, Histology, and Pathology, Faculty of Medicine, Universidad Austral de Chile
17Center for Interdisciplinary Studies on the Nervous System, CISNE, Universidad Austral de Chile, Valdivia, Chile
Javier Blesa
7Comprehensive Neuroscience Center AC (CINAC), HM Puerta del Sur, Madrid Mostoles Hospital, 28938 Madrid, Spain
Pedro Chana-Cuevas
14CETRAM & Faculty of Medical Science Universidad de Santiago de Chile, Chile
German Rehren
15Technology Transfer and Licensing office, Universidad Austral de Chile, Valdivia, Chile
David Schwefel
16Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
Luis Ángel Fernandez
6Department of Microbial Biotechnology, National Biotechnology Center, Superior Council of Scientific Research, Madrid, Spain
Alejandro Rojas-Fernandez
1Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
8Berking Biotechnology, Valdivia, Chile
17Center for Interdisciplinary Studies on the Nervous System, CISNE, Universidad Austral de Chile, Valdivia, Chile
18Institute of Philosophy and Complexity Sciences, Santiago, Chile
Article usage
Posted September 03, 2020.
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity Nanobody
Guillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, Naphak Modhiran, Alberto A Amarilla, Johanna Himelreichs, Alexander A. Khromykh, Constanza Salinas, Teresa Pinto, Yorka Cheuquemilla, Yago Margolles, Natalia López González del Rey, Zaray Miranda-Chacon, Alexei Cuevas, Anne Berking, Camila Deride, Sebastián González-Moraga, Héctor Mancilla, Daniel Maturana, Andreas Langer, Juan Pablo Toledo, Ananda Müller, Benjamín Uberti, Paola Krall, Pamela Ehrenfeld, Javier Blesa, Pedro Chana-Cuevas, German Rehren, David Schwefel, Luis Ángel Fernandez, Alejandro Rojas-Fernandez
bioRxiv 2020.06.09.137935; doi: https://doi.org/10.1101/2020.06.09.137935
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity Nanobody
Guillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, Naphak Modhiran, Alberto A Amarilla, Johanna Himelreichs, Alexander A. Khromykh, Constanza Salinas, Teresa Pinto, Yorka Cheuquemilla, Yago Margolles, Natalia López González del Rey, Zaray Miranda-Chacon, Alexei Cuevas, Anne Berking, Camila Deride, Sebastián González-Moraga, Héctor Mancilla, Daniel Maturana, Andreas Langer, Juan Pablo Toledo, Ananda Müller, Benjamín Uberti, Paola Krall, Pamela Ehrenfeld, Javier Blesa, Pedro Chana-Cuevas, German Rehren, David Schwefel, Luis Ángel Fernandez, Alejandro Rojas-Fernandez
bioRxiv 2020.06.09.137935; doi: https://doi.org/10.1101/2020.06.09.137935
Subject Area
Subject Areas
- Biochemistry (12779)
- Bioengineering (9663)
- Bioinformatics (31224)
- Biophysics (16084)
- Cancer Biology (13163)
- Cell Biology (18831)
- Clinical Trials (138)
- Developmental Biology (10196)
- Ecology (15177)
- Epidemiology (2067)
- Evolutionary Biology (19383)
- Genetics (12871)
- Genomics (17764)
- Immunology (12892)
- Microbiology (30175)
- Molecular Biology (12594)
- Neuroscience (65838)
- Paleontology (486)
- Pathology (2038)
- Pharmacology and Toxicology (3514)
- Physiology (5442)
- Plant Biology (11277)
- Synthetic Biology (3116)
- Systems Biology (7762)
- Zoology (1756)